Detection of three types of hepatitis C virus in blood donors: investigation of type‐specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities

Transfusion

Volumn 33, Issue 1, 1993, Pages 7-13

  McOmish, F ^b   Chan, S W ^b   Dow, B C ^b   Gillon, J ^b   Frame, W D ^b   Crawford, R J ^b   Yap, P L ^b   Follett, E A ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; VIRUS RNA;

ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; CROSS REACTION; DISEASE ASSOCIATION; ENZYME ASSAY; ENZYME IMMUNOASSAY; GENE AMPLIFICATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SCREENING TEST; SEROLOGY; UNITED KINGDOM; VIRUS DETECTION; VIRUS TYPING;

ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; BLOOD DONORS; HEPACIVIRUS; HEPATITIS ANTIBODIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMAN; NORTHERN IRELAND; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RNA, VIRAL; SCOTLAND; SUBSTANCE ABUSE, INTRAVENOUS; SUPPORT, NON-U.S. GOV'T;

EID: 0027509074     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1993.33193142314.x     Document Type: Article

References (35)

1. Isolation of a cDNA clone derived from a blood‐borne non‐A, non‐B viral hepatitis genome
2. Genetic organization and diversity of the hepatitis C virus
3. An assay for circulating antibodies to a major etiologic virus of human non‐A, non‐B hepatitis
4. Evaluation of antibodies to hepatitis C virus in a study of transfusion‐associated hepatitis
5. Japanese Red Cross Non‐A Non‐B Hepatitis Research Group
6. There are two major types of hepatitis C virus in Japan
7. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions
8. Typing of hepatitis C virus genomes by restriction fragment length polymorphism
9. A second group of hepatitis C viruses
10. Distribution of plural HCV types in Japan
11. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease
12. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non‐A, non‐B hepatitis
13. Structure and organization of the hepatitis C virus genome isolated from human carriers
14. Serological responses to infection with three different types of hepatitis C virus (letter)
15. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants
16. Use of several second generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non‐virus inactivated factor VIII and IX concentrates
17. Hepatitis C viraemia in United Kingdom blood donors: a multicentre study
18. Human immunodeficiency virus‐infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers
19. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus
20. Characterization of nuclcotide sequences from European hepatitis C virus isolates
21. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5′ untranslated region and poly(A) tails at the 3′ end
22. A comprehensive set of sequence analysis programs for the VAX
23. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1
24. Typing hepatitis C virus by polymerase chain reaction with type‐specific primers: application to clinical surveys and tracing infectious sources
25. Clinical backgrounds of the patients having different types of hepatitis C virus genomes
26. Analysis of genomic variability of hepatitis C virus
27. Two French genotypes of hepatitis C virus: homology of the predominant genotype with the prototype American strain
28. Severity of liver disease with different hepatitis C viral clones (letter)
29. Risk factors in hepatitis C virus‐infected blood donors
30. Confirmation of hepatitis C virus infection by new four‐antigen recombinant immunoblot assay
31. Patterns of serological markers in transfusion‐transmitted hepatitis C virus infection using second generation HCV assays
32. Serological markers of posttransfusion hepatitis C viral infection
33. Prevalence of antibody to hepatitis C virus in a blood donor population
34. Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors
35. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non‐A,non‐B hepatitis